Pembrolizumab vs Rosuvastatin

## Pembrolizumab vs Rosuvastatin: Overview

This comparison examines the pharmacological differences between **Pembrolizumab** and **Rosuvastatin**.

## Mechanism of Action

**Pembrolizumab**: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

**Rosuvastatin**: Competitive inhibitor of HMG-CoA reductase.

## Pharmacokinetics

**Half-life**: Pembrolizumab — 26 days; Rosuvastatin — 19 hours.

## Chemical Properties

**Molecular Formula**: Pembrolizumab — N/A; Rosuvastatin — C22H28FN3O6S.

**Molecular Weight**: Pembrolizumab — N/A; Rosuvastatin — 481.5390 g/mol.

**Type**: Pembrolizumab — Antibody; Rosuvastatin — Small molecule.